Cargando…

Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics

ABSTRACT: Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, kil...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Manoj Kumar, Kumari, Indu, Singh, Bijender, Sharma, Krishna Kant, Tiwari, Santosh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749913/
https://www.ncbi.nlm.nih.gov/pubmed/35015145
http://dx.doi.org/10.1007/s00253-021-11646-8
_version_ 1784631342607106048
author Yadav, Manoj Kumar
Kumari, Indu
Singh, Bijender
Sharma, Krishna Kant
Tiwari, Santosh Kumar
author_facet Yadav, Manoj Kumar
Kumari, Indu
Singh, Bijender
Sharma, Krishna Kant
Tiwari, Santosh Kumar
author_sort Yadav, Manoj Kumar
collection PubMed
description ABSTRACT: Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, killing of pathogens and induction of host cells are few of the important probiotic attributes which affect several functions of the host. In addition, prebiotics and non-digestible food substances selectively promote the growth of probiotics and human health through nutrient enrichment, and modulation of gut microbiota and immune system. This review highlights the role of probiotics and prebiotics alone and in combination (synbiotics) in the modulation of immune system, treatment of infections, management of inflammatory bowel disease and cancer therapy. KEY POINTS: • Probiotics and their derivatives against several human diseases. • Prebiotics feed probiotics and induce several functions in the host. • Discovery of novel and biosafe products needs attention for human health.
format Online
Article
Text
id pubmed-8749913
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87499132022-01-11 Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics Yadav, Manoj Kumar Kumari, Indu Singh, Bijender Sharma, Krishna Kant Tiwari, Santosh Kumar Appl Microbiol Biotechnol Mini-Review ABSTRACT: Probiotics have been considered as an economical and safe alternative for the treatment of a large number of chronic diseases and improvement of human health. They are known to modulate the host immunity and protect from several infectious and non-infectious diseases. The colonization, killing of pathogens and induction of host cells are few of the important probiotic attributes which affect several functions of the host. In addition, prebiotics and non-digestible food substances selectively promote the growth of probiotics and human health through nutrient enrichment, and modulation of gut microbiota and immune system. This review highlights the role of probiotics and prebiotics alone and in combination (synbiotics) in the modulation of immune system, treatment of infections, management of inflammatory bowel disease and cancer therapy. KEY POINTS: • Probiotics and their derivatives against several human diseases. • Prebiotics feed probiotics and induce several functions in the host. • Discovery of novel and biosafe products needs attention for human health. Springer Berlin Heidelberg 2022-01-11 2022 /pmc/articles/PMC8749913/ /pubmed/35015145 http://dx.doi.org/10.1007/s00253-021-11646-8 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Mini-Review
Yadav, Manoj Kumar
Kumari, Indu
Singh, Bijender
Sharma, Krishna Kant
Tiwari, Santosh Kumar
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
title Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
title_full Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
title_fullStr Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
title_full_unstemmed Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
title_short Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
title_sort probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749913/
https://www.ncbi.nlm.nih.gov/pubmed/35015145
http://dx.doi.org/10.1007/s00253-021-11646-8
work_keys_str_mv AT yadavmanojkumar probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics
AT kumariindu probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics
AT singhbijender probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics
AT sharmakrishnakant probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics
AT tiwarisantoshkumar probioticsprebioticsandsynbioticssafeoptionsfornextgenerationtherapeutics